User:Rithish Nimmagadda: Difference between revisions

Jump to navigation Jump to search
 
(17 intermediate revisions by the same user not shown)
Line 20: Line 20:




==Pages Authored/Co-authored/Collaborated==
==Pages Authored==


<div style="-moz-column-count:8; column-count:2;">
<div style="-moz-column-count:8; column-count:2;">
Line 36: Line 36:
#[[Elacestrant]]
#[[Elacestrant]]
#[[Pirtobrutinib]]
#[[Pirtobrutinib]]
#[[vonoprazan, amoxicillin, and clarithromycin -(Voquezna)]]
#[[vonoprazan, amoxicillin, and clarithromycin]]
#[[Iptacopa]]
#[[GERSTMANN-STRÄUSSLER-SCHEINKER SYNDROME]]
#[[Rumination disorder]]
#[[Birt-Hogg-Dubé syndrome]]
#[[Ischemic hepatitis]]
#[[Diffuse intrinsic pontine glioma]]
#[[Myelin oligodendrocyte glycoprotein antibody-associated disease]]
#[[Tolosa-Hunt syndrome]]
 
==Pages Co-authored/Collaborated==
 
 
 
#[[Eosinophilic esophagitis medical therapy]]
#[[Migraine]]
#[[Cardiac amyloidosis]]
#[[Aspergillosis]]

Latest revision as of 02:34, 10 August 2024

<nowiki>

Your Name

Rithish Nimmagadda,MBBS

Research scholar
Contact:945-278-1660
Email: rithishnvs@gmail.com [1]

Current Position

  • research scholar (list chapters here)



Education

Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India



Pages Authored

  1. Epcoritamab-bysp
  2. Elfabrio
  3. Mirikizumab-mrkz
  4. Bimekizumab
  5. Lotilaner
  6. Quizartinib
  7. Ritlecitinib
  8. Tofersen
  9. Retifanlimab-dlwr
  10. Velmanase alfa-tycv
  11. Elacestrant
  12. Pirtobrutinib
  13. vonoprazan, amoxicillin, and clarithromycin
  14. Iptacopa
  15. GERSTMANN-STRÄUSSLER-SCHEINKER SYNDROME
  16. Rumination disorder
  17. Birt-Hogg-Dubé syndrome
  18. Ischemic hepatitis
  19. Diffuse intrinsic pontine glioma
  20. Myelin oligodendrocyte glycoprotein antibody-associated disease
  21. Tolosa-Hunt syndrome

Pages Co-authored/Collaborated

  1. Eosinophilic esophagitis medical therapy
  2. Migraine
  3. Cardiac amyloidosis
  4. Aspergillosis